Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection.
暂无分享,去创建一个
L. Kauvar | N. Inoue | D. Ogunyemi | E. Maidji | L. Pereira | S. Loghavi | T. Tabata | S. Pepkowitz | M. Zydek | M. Petitt | June Fang-Hoover | M. Tsuge | A. Fong | Yan Zhou
[1] S. Exler,et al. The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[2] S. Adler. Editorial commentary: Primary maternal cytomegalovirus infection during pregnancy: do we have a treatment option? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] M. Ermani,et al. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] G. Parruti,et al. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy--a case-control study of the outcome in children. , 2012, The Journal of infectious diseases.
[5] S. Exler,et al. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[6] D. Cabrol,et al. Functional Screening of TLRs in Human Amniotic Epithelial Cells , 2011, The Journal of Immunology.
[7] L. Pereira. Have we overlooked congenital cytomegalovirus infection as a cause of stillbirth? , 2011, The Journal of infectious diseases.
[8] N. Graf,et al. Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. , 2011, The Journal of infectious diseases.
[9] M. Furione,et al. Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[10] D. Zeltser,et al. Incidence of cytomegalovirus-associated thrombosis and its risk factors: a case-control study. , 2010, Thrombosis research.
[11] S. Shiboski,et al. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. , 2010, The American journal of pathology.
[12] Catherine Klersy,et al. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[13] P. Bernard,et al. Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[14] E. Maidji,et al. Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[15] E. Patsouris,et al. Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: Association with pathological findings , 2008, Journal of medical virology.
[16] D. Ilic,et al. Isolation of human placental fibroblasts. , 2008, Current protocols in stem cell biology.
[17] D. Sheppard,et al. Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production. , 2008, The American journal of pathology.
[18] F. Baldanti,et al. Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. , 2008, The Journal of general virology.
[19] Fernando A. B. Colugnati,et al. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States , 2007, BMC infectious diseases.
[20] T. Compton,et al. Human Cytomegalovirus Envelope Glycoproteins B and H Are Necessary for TLR2 Activation in Permissive Cells1 , 2006, The Journal of Immunology.
[21] B. Sibai,et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. , 2006, The New England journal of medicine.
[22] O. Genbačev,et al. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. , 2006, The American journal of pathology.
[23] E. Maidji,et al. Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[24] W. Britt,et al. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[25] S. Akira,et al. TLR signaling. , 2006, Current topics in microbiology and immunology.
[26] A. Best,et al. Passive immunization during pregnancy for congenital cytomegalovirus infection. , 2005, The New England journal of medicine.
[27] U. Bäder,et al. Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. , 2005, BJOG : an international journal of obstetrics and gynaecology.
[28] L. Gottwald,et al. [Intrauterine growth restriction]. , 2005, Przeglad lekarski.
[29] G. Mor,et al. Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. , 2004, American journal of obstetrics and gynecology.
[30] S. Fisher,et al. Viral and bacterial pathogens at the maternal-fetal interface. , 2004, The Journal of infectious diseases.
[31] S. Fisher,et al. Human Cytomegalovirus Interleukin-10 Downregulates Metalloproteinase Activity and Impairs Endothelial Cell Migration and Placental Cytotrophoblast Invasiveness In Vitro , 2004, Journal of Virology.
[32] K. Lim,et al. Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.
[33] S. Fisher,et al. Human Cytomegalovirus Transmission from the Uterus tothe Placenta Correlates with the Presence of Pathogenic Bacteria andMaternalImmunity , 2003, Journal of Virology.
[34] K. Fowler,et al. Maternal immunity and prevention of congenital cytomegalovirus infection. , 2003, JAMA.
[35] N. Uldbjerg,et al. Antibacterial properties of human amnion and chorion in vitro. , 2001, European journal of obstetrics, gynecology, and reproductive biology.
[36] O. Genbačev,et al. Human Cytomegalovirus Infection of Placental Cytotrophoblasts In Vitro and In Utero: Implications for Transmission and Pathogenesis , 2000, Journal of Virology.
[37] F. Baldanti,et al. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[38] P. Goubau,et al. Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[39] M. Scharff. MONOCLONAL ANTIBODY PRODUCTION , 1999 .
[40] Uwe Marx,et al. Monoclonal Antibody Production , 1997 .
[41] R. Redline,et al. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. , 1995, Human pathology.
[42] M. Debakey,et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis , 1994, Journal of medical virology.
[43] P. Paz,et al. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. , 1993, Virology.
[44] R. K. Miller,et al. Cytomegalovirus infection of the human placenta: an immunocytochemical study. , 1992, Human pathology.
[45] F. P. Hadlock,et al. In utero analysis of fetal growth: a sonographic weight standard. , 1991, Radiology.
[46] M. Daemen,et al. Cytomegalovirus nucleic acid distribution within the human vascular tree. , 1991, The American journal of pathology.
[47] A. G. García,et al. Placental morphology in cytomegalovirus infection. , 1989, Placenta.
[48] E. Lennette,et al. Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections , 1989 .
[49] G. Wood,et al. Human amnion as a model for IgG transport. , 1987, American journal of reproductive immunology and microbiology : AJRIM.
[50] W. Britt,et al. Primary Cytomegalovirus Infection in Pregnancy: Incidence, Transmission to Fetus, and Clinical Outcome , 1987 .
[51] J. Trentin,et al. Replication of cytomegalovirus in human arterial smooth muscle cells , 1985, Journal of virology.
[52] M. Debakey,et al. CYTOMEGALOVIRUS ANTIGEN WITHIN HUMAN ARTERIAL SMOOTH MUSCLE CELLS , 1983, The Lancet.
[53] D. Mckie. Editorial: Where the axe is falling. , 1974, Lancet.